Cancer types
The same diagnosis can mean very different biology.
Common Cancers
Breast Cancer
Breast cancer is biologically diverse. Receptor status and proliferation markers, along with molecular findings, contribute to how the disease is understood and managed.
Explore Breast Cancer molecular considerationsLung Cancer
Lung cancer is one of the areas where molecular characterisation has most changed clinical thinking, particularly in non-small cell histologies.
Explore Lung Cancer molecular considerationsProstate Cancer
Prostate cancer ranges from indolent disease to aggressive, treatment-resistant presentations.
Explore Prostate Cancer molecular considerationsColorectal Cancer
Colorectal cancer behaviour varies by tumour location, pathology and molecular profile.
Explore Colorectal Cancer molecular considerationsOvarian Cancer
Ovarian cancer includes several histological subtypes with different biology and clinical course.
Explore Ovarian Cancer molecular considerationsGastric Cancer
Gastric and gastro-oesophageal cancers vary in pathology and molecular characteristics.
Explore Gastric Cancer molecular considerationsKidney Cancer
Renal cell carcinoma includes several subtypes with distinct biology.
Explore Kidney Cancer molecular considerationsBladder Cancer
Urothelial cancers differ in depth of invasion and molecular profile.
Explore Bladder Cancer molecular considerationsHead & Neck Cancer
Head and neck cancers vary by site, viral association and pathology.
Explore Head & Neck Cancer molecular considerationsThyroid Cancer
Thyroid cancers range from indolent differentiated tumours to aggressive subtypes.
Explore Thyroid Cancer molecular considerationsMelanoma
Melanoma biology and treatment thinking have been substantially shaped by molecular and immune characterisation.
Explore Melanoma molecular considerations
Rare Cancers
Sarcomas
Sarcomas are a heterogeneous group of rare tumours of soft tissue and bone.
Explore Sarcomas molecular considerationsRare and Difficult-to-Treat Cancers
Rare tumours, cancers of unknown primary and treatment-refractory disease often benefit from careful, deliberate characterisation.
Explore Rare and Difficult-to-Treat Cancers molecular considerations
Difficult-to-Treat Cancers
Pancreatic Cancer
Pancreatic cancer often presents late and remains challenging to treat, which makes careful individual assessment important.
Explore Pancreatic Cancer molecular considerationsLiver Cancer
Liver cancer management is shaped by both tumour characteristics and underlying liver function.
Explore Liver Cancer molecular considerations
Molecularly Complex Cancers
Brain Tumours
Central nervous system tumour classification now integrates molecular features with histology.
Explore Brain Tumours molecular considerationsHaematological Malignancies
Leukaemias, lymphomas and myeloma are classified using morphology, immunophenotype and molecular findings.
Explore Haematological Malignancies molecular considerations
Discuss your diagnosis with the institute.
Existing pathology, imaging and molecular reports can be reviewed before anything new is recommended.